• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风缓解的患者体验:一项定性研究。

The Patient Experience of Gout Remission: A Qualitative Study.

作者信息

Tabi-Amponsah Adwoa Dansoa, Stewart Sarah, Hosie Graham, Horne Anne, Dalbeth Nicola

机构信息

University of Auckland, Auckland, New Zealand.

Auckland University of Technology, Auckland, New Zealand.

出版信息

ACR Open Rheumatol. 2023 Aug;5(8):399-406. doi: 10.1002/acr2.11579. Epub 2023 Jul 3.

DOI:10.1002/acr2.11579
PMID:37401117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10425584/
Abstract

OBJECTIVE

Preliminary remission criteria for gout have been developed. However, the patient experience of gout remission has not been described. This qualitative study aimed to understand the patient experience of gout remission and views about the preliminary gout remission criteria.

METHODS

Semistructured interviews were conducted. All participants had gout, had not had a gout flare in the preceding 6 months, and were on urate-lowering medication. Participants were asked to discuss their experience of gout remission and views about the preliminary remission criteria. Interviews were audio recorded and transcribed verbatim. Data were analyzed using a reflexive thematic approach.

RESULTS

Twenty participants with gout (17 male participants, median age 63 years) were interviewed. Four key themes of the patient experience of remission were identified: 1) minimal or no gout symptoms (absence of pain due to gout flares, good physical function, smaller or no tophi), 2) freedom from dietary restrictions, 3) gout is "not on the mind", and 4) multifaceted management strategies to maintain remission (regular urate-lowering therapy, exercise, healthy eating). Participants believed that the preliminary remission criteria contained all relevant domains but considered that the pain and patient global assessment domains overlapped with the gout flares domain. Participants regarded 12 months as a more suitable time frame than 6 months to measure remission.

CONCLUSION

Patients experience gout remission as a return to normality with minimal or no gout symptoms, dietary freedom, and absence of mental load. Patients use a range of management strategies to maintain gout remission.

摘要

目的

痛风的初步缓解标准已经制定。然而,痛风缓解的患者体验尚未得到描述。这项定性研究旨在了解痛风缓解的患者体验以及对痛风初步缓解标准的看法。

方法

进行了半结构化访谈。所有参与者均患有痛风,在过去6个月内未出现痛风发作,且正在接受降尿酸治疗。参与者被要求讨论他们的痛风缓解体验以及对初步缓解标准的看法。访谈进行了录音并逐字转录。使用反思性主题分析法对数据进行了分析。

结果

对20名痛风患者(17名男性参与者,中位年龄63岁)进行了访谈。确定了痛风缓解患者体验的四个关键主题:1)痛风症状极少或没有(无痛风发作引起的疼痛、身体功能良好、痛风石较小或没有),2)摆脱饮食限制,3)不再“惦记”痛风,4)维持缓解的多方面管理策略(定期降尿酸治疗、运动、健康饮食)。参与者认为初步缓解标准涵盖了所有相关领域,但认为疼痛和患者整体评估领域与痛风发作领域存在重叠。参与者认为12个月比6个月更适合作为衡量缓解的时间框架。

结论

患者将痛风缓解体验为恢复正常,痛风症状极少或没有、饮食自由且没有心理负担。患者采用一系列管理策略来维持痛风缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e5/10425584/3de16f9b3c41/ACR2-5-399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e5/10425584/3de16f9b3c41/ACR2-5-399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e5/10425584/3de16f9b3c41/ACR2-5-399-g001.jpg

相似文献

1
The Patient Experience of Gout Remission: A Qualitative Study.痛风缓解的患者体验:一项定性研究。
ACR Open Rheumatol. 2023 Aug;5(8):399-406. doi: 10.1002/acr2.11579. Epub 2023 Jul 3.
2
Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review.以痛风缓解为降尿酸治疗目标:一项批判性综述
Pharmaceuticals (Basel). 2023 May 23;16(6):779. doi: 10.3390/ph16060779.
3
Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study.从患者角度看痛风发作严重程度:定性访谈研究。
Arthritis Care Res (Hoboken). 2022 Feb;74(2):317-323. doi: 10.1002/acr.24475. Epub 2022 Jan 8.
4
Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.双能 CT 研究:痛风暂定缓解标准的同时效度。
Arthritis Res Ther. 2019 Jun 21;21(1):150. doi: 10.1186/s13075-019-1941-8.
5
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.运用德尔菲法和1000Minds共识法制定痛风初步缓解标准
Arthritis Care Res (Hoboken). 2016 May;68(5):667-72. doi: 10.1002/acr.22741.
6
Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study.超声评估单钠尿酸盐负荷预测痛风 2016 缓解标准的达标情况:一项为期 12 个月的研究。
Arthritis Res Ther. 2021 Jul 9;23(1):185. doi: 10.1186/s13075-021-02568-x.
7
'Gout was like the boss'. A qualitative study exploring the impact of gout on employment.痛风就像老板。一项探索痛风对就业影响的定性研究。
RMD Open. 2024 Aug 19;10(3):e004443. doi: 10.1136/rmdopen-2024-004443.
8
Baseline Dual-Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate-Lowering Therapy.基线双能量 CT 尿酸盐体积可预测降尿酸治疗 2 年后痛风缓解的达标情况。
Arthritis Care Res (Hoboken). 2024 Dec;76(12):1657-1665. doi: 10.1002/acr.25414. Epub 2024 Aug 29.
9
Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate-Lowering Therapy During Remission: A Mixed-Methods Study.荷兰痛风患者在缓解期继续或停止降尿酸治疗的观点:一项混合方法研究。
Arthritis Care Res (Hoboken). 2024 Nov;76(11):1574-1583. doi: 10.1002/acr.25392. Epub 2024 Jul 23.
10
The experience of a gout flare: a meta-synthesis of qualitative studies.痛风发作的体验:定性研究的综合分析。
Semin Arthritis Rheum. 2020 Aug;50(4):805-811. doi: 10.1016/j.semarthrit.2020.06.001. Epub 2020 Jun 9.

引用本文的文献

1
'All I Do Is Sit in a Chair Until the Pain Fades'-Experiences of Living With Gout.“我所能做的就是坐在椅子上直到疼痛消退”——痛风患者的生活经历
Health Expect. 2025 Jun;28(3):e70302. doi: 10.1111/hex.70302.
2
Quality of life and clinical gout assessments during pegloticase with and without methotrexate co-therapy: MIRROR randomized controlled trial exploratory findings.聚乙二醇化尿酸酶联合或不联合甲氨蝶呤治疗期间的生活质量和临床痛风评估:MIRROR随机对照试验的探索性结果。
Rheumatol Adv Pract. 2024 Nov 29;8(4):rkae145. doi: 10.1093/rap/rkae145. eCollection 2024.
3
Baseline Dual-Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate-Lowering Therapy.

本文引用的文献

1
Predictors of Patient and Physician Assessments of Gout Control.痛风控制的患者和医生评估的预测因素。
Arthritis Care Res (Hoboken). 2023 Jun;75(6):1287-1291. doi: 10.1002/acr.25046. Epub 2022 Dec 28.
2
'It's just a great muddle when it comes to food': a qualitative exploration of patient decision-making around diet and gout.“说到食物,简直是一团糟”:关于患者饮食与痛风决策的质性探索
Rheumatol Adv Pract. 2021 Aug 13;5(3):rkab055. doi: 10.1093/rap/rkab055. eCollection 2021.
3
Using naturalistic inquiry to inform qualitative description.
基线双能量 CT 尿酸盐体积可预测降尿酸治疗 2 年后痛风缓解的达标情况。
Arthritis Care Res (Hoboken). 2024 Dec;76(12):1657-1665. doi: 10.1002/acr.25414. Epub 2024 Aug 29.
运用自然主义探究为质性描述提供信息。
Nurse Res. 2021 Sep 9;29(3):29-33. doi: 10.7748/nr.2021.e1788. Epub 2021 Apr 29.
4
Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study.从患者角度看痛风发作严重程度:定性访谈研究。
Arthritis Care Res (Hoboken). 2022 Feb;74(2):317-323. doi: 10.1002/acr.24475. Epub 2022 Jan 8.
5
Australian patient perspectives on the impact of gout.澳大利亚患者对痛风影响的看法。
Int J Rheum Dis. 2020 Oct;23(10):1372-1378. doi: 10.1111/1756-185X.13934. Epub 2020 Aug 10.
6
2020 American College of Rheumatology Guideline for the Management of Gout.2020 年美国风湿病学会痛风管理指南。
Arthritis Rheumatol. 2020 Jun;72(6):879-895. doi: 10.1002/art.41247. Epub 2020 May 11.
7
Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout.痛风患者疾病活动状态评估的 flares 发生率阈值。
J Rheumatol. 2021 Feb;48(2):293-298. doi: 10.3899/jrheum.191242. Epub 2020 May 1.
8
Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.双能 CT 研究:痛风暂定缓解标准的同时效度。
Arthritis Res Ther. 2019 Jun 21;21(1):150. doi: 10.1186/s13075-019-1941-8.
9
Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.新西兰奥特亚罗瓦的痛风:公平危机依然显而易见。
N Z Med J. 2018 Nov 9;131(1485):8-12.
10
How patients with gout become engaged in disease management: a constructivist grounded theory study.痛风患者如何参与疾病管理:一项建构主义扎根理论研究。
Arthritis Res Ther. 2018 Jun 1;20(1):110. doi: 10.1186/s13075-018-1608-x.